CY1505A - Improvements in or relating to cephalosporin derivatives - Google Patents

Improvements in or relating to cephalosporin derivatives

Info

Publication number
CY1505A
CY1505A CY1505A CY150584A CY1505A CY 1505 A CY1505 A CY 1505A CY 1505 A CY1505 A CY 1505A CY 150584 A CY150584 A CY 150584A CY 1505 A CY1505 A CY 1505A
Authority
CY
Cyprus
Prior art keywords
relating
cephalosporin derivatives
cephalosporin
derivatives
Prior art date
Application number
CY1505A
Other languages
English (en)
Inventor
Gary Lowell Engel
Joseph Michael Indelicato
Harry Albert Rose
Shane Lawrence Joseph Mc
Kuo Shang Yang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CY1505A publication Critical patent/CY1505A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/227-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CY1505A 1983-12-01 1984-11-28 Improvements in or relating to cephalosporin derivatives CY1505A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/556,887 US4600773A (en) 1983-12-01 1983-12-01 Crystalline cephalexin hydrochloride monohydrate

Publications (1)

Publication Number Publication Date
CY1505A true CY1505A (en) 1990-08-03

Family

ID=24223233

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1505A CY1505A (en) 1983-12-01 1984-11-28 Improvements in or relating to cephalosporin derivatives

Country Status (46)

Country Link
US (1) US4600773A (ar)
EP (1) EP0143658B1 (ar)
JP (1) JPS60132990A (ar)
KR (1) KR870000527B1 (ar)
AT (1) AT390616B (ar)
AU (1) AU566080B2 (ar)
BE (1) BE901142A (ar)
BG (1) BG40966A3 (ar)
BR (1) BR8406037A (ar)
CH (1) CH661732A5 (ar)
CS (1) CS248725B2 (ar)
CY (1) CY1505A (ar)
DD (1) DD229410A5 (ar)
DE (1) DE3443065A1 (ar)
DK (1) DK158354C (ar)
ES (1) ES538019A0 (ar)
FI (1) FI80274C (ar)
FR (1) FR2555990B1 (ar)
GB (1) GB2150566B (ar)
GR (1) GR81043B (ar)
GT (1) GT198400146A (ar)
HK (1) HK92089A (ar)
HU (1) HU192516B (ar)
IE (1) IE57886B1 (ar)
IL (1) IL73639A (ar)
IN (1) IN163078B (ar)
IT (1) IT1177329B (ar)
JO (1) JO1347B1 (ar)
LU (1) LU85650A1 (ar)
MA (1) MA20279A1 (ar)
MX (1) MX159670A (ar)
MY (1) MY102966A (ar)
NL (1) NL8403588A (ar)
NO (1) NO844711L (ar)
NZ (1) NZ210357A (ar)
OA (1) OA07876A (ar)
PH (1) PH20849A (ar)
PL (1) PL146014B1 (ar)
PT (1) PT79553B (ar)
SE (1) SE464026B (ar)
SG (1) SG59789G (ar)
SU (1) SU1251807A3 (ar)
YU (1) YU45680B (ar)
ZA (1) ZA849224B (ar)
ZM (1) ZM6384A1 (ar)
ZW (1) ZW19084A1 (ar)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2555989B1 (fr) * 1983-12-06 1987-02-20 Bristol Myers Sa Monohydrate de chlorocephadroxyle
JPS60142987A (ja) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd セフアロスポリン誘導体
DE3485860T2 (de) * 1983-12-29 1993-01-14 Mochida Pharm Co Ltd Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
US4775751A (en) * 1985-06-03 1988-10-04 Eli Lilly & Company Process for cephalexin hydrochloride alcoholates
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
JPS63132893A (ja) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
US5721229A (en) * 1995-12-26 1998-02-24 Veterinary Pharmacy Corporation Soluble forms of cephalosporins and treatment of animals
GB9717629D0 (en) 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents
AT413282B (de) * 2002-02-01 2006-01-15 Sandoz Ag Kristalline salze der 7-(((5-amino-1,2,4-thiadiazol-3-yl) (fluoromethoxy-imino)acetyl)amino)-3- ((imino-1-piperazinylmethyl)
US20040033262A1 (en) * 2002-08-19 2004-02-19 Orchid Health Care Sustained release pharmaceutical composition of a cephalosporin antibiotic

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507861A (en) * 1966-09-14 1970-04-21 Lilly Co Eli Certain 3-methyl-cephalosporin compounds
US3655656A (en) * 1970-06-04 1972-04-11 Lilly Co Eli Crystalline cephalexin monohydrate
DE2317179C2 (de) * 1973-04-05 1982-11-25 Bristol-Myers Co., 10154 New York, N.Y. Verfahren zur Herstellung der relativ wasserunlöslichen kristallinen Form von Cefalexinmonohydrat
US3985747A (en) * 1974-05-24 1976-10-12 Bristol-Myers Company Crystalline sesquihydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
JPS50151890A (ar) * 1974-05-30 1975-12-06
CH642850A5 (it) * 1978-10-20 1984-05-15 Ausonia Farma Srl Composizioni farmaceutiche ad attivita antibatterica contro infezioni da germi gram-positivi e gram-negativi.
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device

Also Published As

Publication number Publication date
FR2555990A1 (fr) 1985-06-07
FI80274B (fi) 1990-01-31
KR850004765A (ko) 1985-07-27
ZM6384A1 (en) 1985-07-22
YU45680B (sh) 1992-07-20
SE8405954D0 (sv) 1984-11-26
AU3589784A (en) 1985-06-06
EP0143658A3 (en) 1986-02-12
CH661732A5 (de) 1987-08-14
NZ210357A (en) 1988-05-30
AU566080B2 (en) 1987-10-08
FI80274C (fi) 1990-05-10
OA07876A (fr) 1986-11-20
HUT35685A (en) 1985-07-29
JO1347B1 (ar) 1986-11-30
MA20279A1 (fr) 1985-07-01
DK158354C (da) 1990-10-01
PL250593A1 (en) 1985-07-30
IN163078B (ar) 1988-08-06
JPS60132990A (ja) 1985-07-16
EP0143658B1 (en) 1989-03-22
SG59789G (en) 1989-12-29
ATA373284A (de) 1989-11-15
MY102966A (en) 1993-03-31
DK561284A (da) 1985-06-02
PT79553A (en) 1984-12-01
IT8423746A0 (it) 1984-11-27
BR8406037A (pt) 1985-08-27
IT8423746A1 (it) 1986-05-27
IE843033L (en) 1985-06-01
NO844711L (no) 1985-06-03
YU199684A (en) 1987-02-28
ZW19084A1 (en) 1985-06-12
HK92089A (en) 1989-11-24
BG40966A3 (en) 1987-03-14
GB8430073D0 (en) 1985-01-09
NL8403588A (nl) 1985-07-01
AT390616B (de) 1990-06-11
FI844631L (fi) 1985-06-02
US4600773A (en) 1986-07-15
DE3443065C2 (ar) 1989-03-23
JPH0548234B2 (ar) 1993-07-20
ES8602011A1 (es) 1985-11-01
MX159670A (es) 1989-08-02
FI844631A0 (fi) 1984-11-26
DD229410A5 (de) 1985-11-06
FR2555990B1 (fr) 1986-12-26
SU1251807A3 (ru) 1986-08-15
ZA849224B (en) 1986-07-30
SE8405954L (sv) 1985-06-02
GB2150566A (en) 1985-07-03
EP0143658A2 (en) 1985-06-05
SE464026B (sv) 1991-02-25
DE3443065A1 (de) 1985-06-20
GB2150566B (en) 1987-08-26
GR81043B (en) 1985-03-27
LU85650A1 (fr) 1985-07-17
PH20849A (en) 1987-05-08
DK561284D0 (da) 1984-11-27
IE57886B1 (en) 1993-05-05
CS248725B2 (en) 1987-02-12
GT198400146A (es) 1986-05-20
DK158354B (da) 1990-05-07
PL146014B1 (en) 1988-12-31
IL73639A (en) 1988-06-30
PT79553B (en) 1986-12-15
IT1177329B (it) 1987-08-26
KR870000527B1 (ko) 1987-03-14
HU192516B (en) 1987-06-29
IL73639A0 (en) 1985-02-28
ES538019A0 (es) 1985-11-01
BE901142A (fr) 1985-05-28

Similar Documents

Publication Publication Date Title
GB2141778B (en) Improvements in or relating to hinges
GB2134522B (en) Cephalosporin derivatives
IL70075A0 (en) Improvements in or relating to 3-aryl-5-pyrazole derivatives
GB2145408B (en) Improvements in or relating to preparing sodium cefuroxime
EP0127992A3 (en) Cephalosporin derivatives
PT78985A (en) Improvements in or relating to cephalosporins
GB2155654B (en) Improvements in or relating to eyeguards
GR80670B (en) Improvements on or relating to 3-bicyclic pyridinium-methyl cephalosporin
IL73639A0 (en) Improvements in or relating to cephalosporin derivatives
GB2149122B (en) Improvements in or relating to sensors
GB2149121B (en) Improvements in or relating to sensors
DE3474532D1 (en) Improvements in or relating to trailers
GB2145899B (en) Improvements in or relating to telecines
GB2137997B (en) Improvements in or relating to indolylglycyl cephalosporin derivatives
IL71497A0 (en) Improvements in or relating to benzothienylglycyl cephalosporin derivatives
GB2149123B (en) Improvements in or relating to sensors
IL71496A0 (en) Improvements in or relating to benzothienylglycyl cephalosporin derivatives
ZM1684A1 (en) Improvements in or relating to naphthylglycyl cephalosporin derivatives
GB2146768B (en) Improvements in or relating to surveying techniques
ZW4484A1 (en) Improvements in or relating to napthylglycyl cephalosporin derivatives
IL70854A0 (en) Improvements in or relating to benzazepine derivatives
GB2137137B (en) Improvements in or relating to jigs
IL68500A0 (en) Improvement in or relating to naphthalenamine derivatives
GB8318245D0 (en) Cephalosporin derivatives